Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>HTSC Raises JD HEALTH's TP to HKD67.1; Firm Actively Exploring Medical AI
Recommend 7 Positive 8 Negative 2 |
||||
|
||||
|
JD HEALTH (06618.HK) achieved a total revenue of RMB35.29 billion in 1H25, up 24.5% YoY, surpassing the expected growth of 20.2% by the market, according to Huatai Securities' research report. In the broker's estimate, JD HEALTH is likely to continue benefiting from the rapid traffic growth of JD's main site. According to QuestMobile, JD APP's daily active users grew by 44.8%/ 33.4%/ 46.4% YoY from May to July 2025. While benefiting from the increased advertising demand from upstream partners, JD HEALTH is gradually retaining new users through its continuously strengthened omnichannel medical service capabilities (B2C+O2O). In addition, JD HEALTH's proactive exploration in the field of medical AI will be a crucial lever for continuously enhancing operational efficiency and optimizing user experience. Consequently, Huatai Securities kept a Buy rating unchanged for JD HEALTH, with a target price lifted from HKD42.1 to HKD67.1. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
